Worthlessness

Worthlessness is a profound psychological state characterized by feelings of having no value, significance, or purpose in life. Depression (also called major depression, major depressive disorder, or clinical depression) is different. It can cause severe symptoms that affect how a person feels, thinks, and handles daily activities, such as sleeping, eating, or working. Individuals experiencing worthlessness often believe they have nothing valuable to offer and may see themselves as a burden to others.

This psychological state extends beyond temporary self-doubt or disappointment. The secondary symptoms of MDE are appetite or weight changes (AW), sleep difficulties (insomnia or hypersomnia), psychomotor agitation or retardation (PAR), fatigue or loss of energy (FE), diminished ability to think or concentrate (C), feelings of worthlessness or excessive guilt (FW), and suicidality (SU). Worthlessness represents a core symptom of major depressive disorder and can significantly impair an individual's ability to function in daily life.

Table of Contents

• Understanding Worthlessness
• Connection to Mental Health Conditions
• Risk Factors and Warning Signs
• Treatment Approaches
• When to Seek Help
• Recovery and Support
• Frequently Asked Questions
• How Therapy Can Help

Understanding Worthlessness

Feelings of worthlessness involve more than just low self-esteem or temporary negative thoughts. Feelings of worthlessness or excessive or inappropriate guilt nearly every day. This psychological state represents a persistent belief that one lacks inherent value or purpose, often accompanied by intense self-criticism and shame.

Clinical Definition and Criteria

According to the DSM-5-TR (2022), worthlessness is one of the nine diagnostic criteria for major depressive disorder. Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day (not merely self-reproach or guilt about being sick). To meet clinical criteria, these feelings must be present nearly every day for at least two weeks and represent a change from previous functioning.

To diagnose MDD, a patient must show at least five symptoms. These symptoms must last for the same 2-week period. They must also show a change from how they used to function. Key symptoms include feeling sad, losing interest in things, changes in appetite, sleep issues, feeling tired, feeling worthless or guilty, and thinking about death a lot.

Prevalence and Impact

Recent data reveals the significant prevalence of depression and associated symptoms like worthlessness in the United States. During August 2021–August 2023, 13.1% of U.S. adolescents and adults age 12 and older had depression in a given 2-week period. Depression prevalence was higher in females than males and decreased with increasing age. Depression prevalence also increased as family income level decreased; more than one in five adolescents and adults with family income below the poverty level (22.1%) had depression.

The impact extends across demographics, with certain populations experiencing higher rates. Most recent 2024 data show 5% or 1 in 20 U.S. adults regularly reported feelings of depression. Most recent 2024 data show 19% or 1 in 5 U.S. adults were ever told by a doctor or other healthcare professional that they had any type of depression disorder.

Connection to Mental Health Conditions

Major Depressive Disorder

Worthlessness serves as a core symptom of major depressive disorder (MDD). In addition, patients with severe depression would be characterized by thoughts of death and feelings of worthlessness. In our study, the presence of the anhedonia main criterion indicates severe depression, especially when accompanied by feelings of worthlessness or excessive guilt, and thoughts of death.

Research distinguishes between moderate and severe depression based on symptom clusters. They found that major depression symptoms are best represented by somatic and non-somatic factors. The somatic items included sleep difficulties (SD), appetite or weight changes, poor concentration, fatigue, and psychomotor agitation/retardation. The non-somatic factor consisted of affective items such as depressed mood, anhedonia, feelings of worthlessness, and thoughts of death.

Suicide Risk

The relationship between worthlessness and suicide risk demands serious attention. Clinical factors had the strongest associations with suicide, including any mental disorder (OR=13.1, 95% CI 9.9 to 17.4) and a history of self-harm (OR=10.1, 95% CI 6.6 to 15.6).

Recent research emphasizes this connection: Additional studies have indicated that hopelessness is a predictor of depression (Choi & Shin, 2023), and both psychological factors would strongly predict suicidal risk in young populations (Gómez-Tabares et al., 2024; Núñez et al., 2023). Similarly, Wang et al. (2015) found that hopelessness, depression, and impulsivity contribute significantly to the development of suicidal risk and behavior, but such contribution depends on how these factors interact with each other.

Associated Mental Health Conditions

Worthlessness commonly appears alongside other mental health conditions:

• Anxiety Disorders: During 2022, about one in five adults age 18 and older experienced any symptoms of anxiety (18.2%) or symptoms of depression (21.4%) in the past 2 weeks. The percentages of adults with mild, moderate, or severe symptoms of both anxiety and depression were highest among adults ages 18–29 and decreased with age and were higher among women than men.
• Trauma-Related Conditions: Research indicates strong connections between childhood trauma and later development of worthlessness feelings
• Substance Use Disorders: Feelings of worthlessness may lead to or result from substance use as a coping mechanism

Risk Factors and Warning Signs

Individual Risk Factors

Several factors increase vulnerability to experiencing worthlessness:

• Demographic Factors: During 2009–2012, 7.6% of Americans aged 12 and over had depression (defined as having moderate or severe depressive symptoms in the past 2 weeks). Depression was more prevalent among females than males and among adults aged 40–59 than those of other age groups. Rates of any depressive symptoms were lower among non-Hispanic white persons than among Hispanic and non-Hispanic black persons.
• Socioeconomic Status: Persons living below the poverty level were nearly 2½ times more likely to have depression than those at or above the poverty level.
• Living Circumstances: Depression was higher among adults living alone (6.4%) compared with adults living with others (4.1%), for both men and women, across most race and Hispanic-origin groups, and by family income. Adults who reported never or rarely receiving social and emotional support and living alone were almost twice as likely to report feelings of depression than those never or rarely receiving social and emotional support and living with others (19.6% compared with 11.6%, respectively).

Warning Signs

Recognizing warning signs of worthlessness is crucial for early intervention:

Emotional Indicators:

• Persistent feelings of being a burden to others
• Excessive self-blame and guilt
• Belief that one's absence would benefit others
• Inability to recognize personal accomplishments or positive qualities

Behavioral Changes:

• Social withdrawal and isolation
• Neglect of self-care activities
• Decreased productivity at work or school
• Avoidance of previously enjoyed activities

Cognitive Patterns:

• Persistent negative self-talk
• Catastrophic thinking about personal worth
• Difficulty accepting compliments or positive feedback
• Rumination on perceived failures or mistakes

Treatment Approaches

Cognitive Behavioral Therapy (CBT)

CBT remains the gold standard for treating depression and associated worthlessness. CBT had moderate to large effects compared to control conditions such as care as usual and waitlist (g=0.79; 95% CI: 0.70‐0.89), which remained similar in sensitivity analyses and were still significant at 6‐12 month follow‐up. The effects of CBT did not differ significantly from those of pharmacotherapies at the short term, but were significantly larger at 6‐12 month follow‐up (g=0.34; 95% CI: 0.09‐0.58), although the number of trials was small, and the difference was not significant in all sensitivity analyses. CBT appears to be as effective as pharmacotherapies at the short term, but more effective at the longer term.

The effectiveness of CBT has been thoroughly documented: A meta-analysis of 115 studies has shown that CBT is an effective treatment strategy for depression and combined treatment with pharmacotherapy is significantly more effective than pharmacotherapy alone. Evidence also suggests that relapse rate of patients treated with CBT is lower in comparison to the patients treated with pharmacotherapy alone.

Integrated Treatment Approaches

Modern treatment emphasizes comprehensive care coordination: Research suggests that a "collaborative care approach" can improve the overall health of people with depression. In this approach, primary care providers, care managers, and psychiatric consultants work together to provide mental and physical health care at the same location. Collaborative care is not yet available in all primary care offices or clinics—ask your health care provider if it's an option for you.

Digital and Web-Based Interventions

Recent advances in technology have expanded treatment options: Most studies assessed the efficacy of internet-based CBT (ICBT) or web-delivered CBT (wCBT). Large effects on depression symptoms [6]. CBT has been considered an effective treatment intervention for major depressive disorder (MDD). For instance, one study reported that 75.9% of participants achieved remission following the CBT intervention. This shows that CBT can result in high rates of depression remission [8].

Medication Options

While therapy remains crucial, medication can be an important component of treatment: Most people with depression benefit from mental health treatment. Once you begin treatment, you should gradually start to feel better.

When to Seek Help

Immediate Crisis Situations

If you experience thoughts of suicide or self-harm, immediate help is available:

• 988 Suicide & Crisis Lifeline: Call or text 988 for 24/7 support
• Crisis Text Line: Text HOME to 741741
• Emergency Services: Call 911 for immediate danger

$836 million, an increase of $334 million, to the 988 Suicide & Crisis Lifeline. From July to December 2022, the 988 Lifeline answered more than 2.1 million contacts. The requested funds, to be dispersed to states, local crisis centers, tribes and tribal organizations, and the system administrator, would scale and strengthen the 988 crisis care operation to respond to the 9 million contacts anticipated in FY 2024.

Professional Help Indicators

Consider seeking professional help when:

• Feelings of worthlessness persist for more than two weeks
• Symptoms interfere with daily functioning
• Physical symptoms accompany emotional distress
• Support from friends and family isn't sufficient

Finding Mental Health Services

Resources for locating appropriate care include:

The National Directory of Mental Health Treatment Facilities - 2024 is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2023 National Substance Use and Mental Health Services Survey (N-SUMHSS).

• SAMHSA's National Helpline: 1-800-662-HELP (4357)
• GoodTherapy.org Directory for qualified therapists in your area
• Insurance provider directories for covered mental health services
• Community mental health centers for affordable care options

Recovery and Support

Building Resilience

Recovery from worthlessness involves developing protective factors:

Social Support: SAMHSA is committed to promoting the prevention, treatment, and recovery to those who have serious mental illness. SAMHSA's Behavioral Health Career Navigator is a tool for those interested in a job or career in the fields of mental health and substance use.

Self-Care Strategies:

• Establishing regular sleep patterns
• Engaging in physical activity
• Maintaining nutritious eating habits
• Practicing mindfulness and relaxation techniques

Long-Term Management

Sustained recovery requires ongoing attention: The highly recurrent nature of Major Depressive Disorder is a major contributor to disability and health care costs. Several studies indicate that recurrence may be prevented with Preventive Cognitive Therapy (PCT). The majority of individuals with MDD experience more than one episode and the risk of another episode increases with each relapse or recurrence (10).

Support Networks

Building and maintaining support systems proves essential for recovery:

• Peer Support Groups: Connect with others experiencing similar challenges
• Family and Friends: Educate loved ones about mental health to improve understanding
• Online Communities: Access support through moderated mental health forums
• Professional Networks: Maintain regular contact with treatment providers

Frequently Asked Questions

Q: Is feeling worthless the same as having low self-esteem? A: While related, worthlessness extends beyond low self-esteem. In sadness, you might feel regret or remorse for something you said or did, but you won't experience any permanent sense of worthlessness or guilt as you might with depression. One of the diagnostic features of depression is this kind of self-diminishing, negative thought patterns.

Q: How long do feelings of worthlessness typically last during depression? A: Clinical depression requires symptoms to persist for at least two weeks, but episodes can last much longer without treatment. A key part of diagnosing MDD is that symptoms must last for at least a two-week period. This helps tell MDD apart from short mood swings.

Q: Can children experience worthlessness? A: Yes, children and adolescents can experience worthlessness as part of depression. Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feels sad, empty, hopeless) or observation made by others (e.g., appears tearful). (Note: In children and adolescents, can be irritable mood.)

Q: What's the difference between guilt and worthlessness? A: Guilt typically relates to specific actions or events, while worthlessness represents a global negative view of oneself. Both can occur in depression but represent distinct experiences.

Q: Can worthlessness occur without depression? A: While closely associated with depression, feelings of worthlessness can occur in other conditions including anxiety disorders, trauma-related conditions, and during significant life stressors.

Q: How effective is online therapy for treating worthlessness? A: Research shows web-based CBT can be highly effective. CBT was also effective as unguided self‐help intervention (g=0.45; 95% CI: 0.31‐0.60), in institutional settings (g=0.65; 95% CI: 0.21‐1.08), and in children and adolescents (g=0.41; 95% CI: 0.25‐0.57). We can conclude that the efficacy of CBT in depression is documented across different formats, ages, target groups, and settings.

How Therapy Can Help

Professional therapy offers evidence-based approaches to address worthlessness effectively. At GoodTherapy.org, you can connect with qualified mental health professionals who specialize in treating depression and related conditions.

Benefits of Professional Support

Working with a therapist provides:

• Personalized treatment planning based on your specific needs
• Safe space to explore difficult emotions without judgment
• Evidence-based interventions proven to reduce symptoms
• Ongoing support throughout the recovery process
• Skills and strategies for long-term wellness

Finding the Right Therapist

Use our therapist directory to search for mental health professionals in your area who specialize in:

• Depression and mood disorders
• Cognitive behavioral therapy
• Trauma-informed care
• Integrated treatment approaches

Remember, reaching out for help demonstrates strength, not weakness. Recovery is possible, and you don't have to face these challenges alone.

References:

1. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
2. American Psychological Association. (2023). Clinical practice guideline for the treatment of depression across three age cohorts. https://www.apa.org/depression-guideline
3. Centers for Disease Control and Prevention. (2024). Mental health conditions and care. https://www.cdc.gov/mental-health/about-data/conditions-care.html
4. Centers for Disease Control and Prevention. (2024). National health statistics reports, no. 213: Symptoms of anxiety and depression among adults: United States, 2022. https://www.cdc.gov/nchs/data/nhsr/nhsr213.pdf
5. Chen, M., Huang, H., Jiang, Q., & Wu, Y. (2025). Effect of dietary live microbe intake on the prevalence and mortality risks of depression and suicidal ideation in adults: Evidence from a nationwide population-based study. Journal of Affective Disorders, 360, 145-156. https://doi.org/10.1016/j.jad.2025.02.001
6. Cuijpers, P., Miguel, C., Harrer, M., Plessen, C. Y., Ciharova, M., Ebert, D., & Karyotaki, E. (2023). Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: A comprehensive meta‐analysis including 409 trials with 52,702 patients. World Psychiatry, 22(1), 105-115. https://doi.org/10.1002/wps.21069
7. de Jonge, M., Blankers, M., Bockting, C. L., van Dijk, M. K., Kikkert, M. J., & Dekker, J. J. (2024). Economic evaluation of preventive cognitive therapy versus care as usual in cognitive behavioral therapy responders. Frontiers in Psychiatry, 14, 1134071. https://doi.org/10.3389/fpsyt.2023.1134071
8. de la Torre-Luque, A., Pemau, A., Ayad-Ahmed, W., Borges, G., Fernandez-Sevillano, J., Garrido-Torres, N., ... & Ayuso-Mateos, J. L. (2023). Risk of suicide attempt repetition after an index attempt: A systematic review and meta-analysis. General Hospital Psychiatry, 81, 51-56. https://doi.org/10.1016/j.genhosppsych.2023.01.007
9. Fazel, S., & Runeson, B. (2020). Suicide. New England Journal of Medicine, 382(3), 266-274. https://doi.org/10.1056/NEJMra1902944
10. Franklin, J. C., Ribeiro, J. D., Fox, K. R., Bentley, K. H., Kleiman, E. M., Huang, X., ... & Nock, M. K. (2023). Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research. Psychological Bulletin, 149(1-2), 1-37. https://doi.org/10.1037/bul0000362
11. Gómez-Tabares, A. S., Suárez-Colorado, Y., & Núñez, C. (2024). The effect of depression and hopelessness on suicidal risk in young people: The mediating role of impulsivity. International Journal of Environmental Research and Public Health, 21(5), 600. https://doi.org/10.3390/ijerph21050600
12. Grover, S., Aneja, J., Sharma, A., Malhotra, S., Varma, S., Basu, D., & Avasthi, A. (2023). Meta-analysis of clinical risk factors for suicide among people presenting to emergency departments and general hospitals with suicidal thoughts and behaviours. Acta Psychiatrica Scandinavica, 148(4), 324-340. https://doi.org/10.1111/acps.13620
13. Harrer, M., Apolinário-Hagen, J., Fritsche, L., Salewski, C., Zarski, A. C., Lehr, D., ... & Ebert, D. D. (2024). Effect of internet-based cognitive-behavioral therapy for depression on quality of life: A systematic review and meta-analysis. Journal of Medical Internet Research, 26(1), e48236. https://doi.org/10.2196/48236
14. Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2023). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 47(5), 645-668. https://doi.org/10.1007/s10608-023-10395-4
15. Large, M., Corderoy, A., & McHugh, C. (2022). Risk factors for suicide in adults: Systematic review and meta-analysis of psychological autopsy studies. Evidence-Based Mental Health, 25(4), 148-155. https://doi.org/10.1136/ebmental-2022-300549
16. Li, Q. S., Shabalin, A. A., DiBlasi, E., Gopal, S., Canuso, C. M., & Docherty, A. R. (2023). Genome-wide association study meta-analysis of suicide death and suicidal behavior. Molecular Psychiatry, 28, 891-900. https://doi.org/10.1038/s41380-022-01828-9
17. Liu, J., Wang, H., Zhang, L., & Chen, Y. (2024). The efficacy of web-based cognitive behavioral therapy with shame intervention for social anxiety disorder: A randomized controlled trial. JMIR Mental Health, 11, e50535. https://doi.org/10.2196/50535
18. Malekzadeh, M., Mirzaee, M. S., Pendar, R., & Dasdar, S. (2025). Lived experiences of adolescents attempted suicide: A phenomenological study. BMC Psychiatry, 25(1), 89. https://doi.org/10.1186/s12888-025-05532-3
19. Milton, A. C., Davenport, T. A., Iorfino, F., Flego, A., Burns, J. M., & Hickie, I. B. (2024). Suicidal thoughts and behaviors and their associations with transitional life events in men and women: Findings from an international web-based sample. Journal of Clinical Psychiatry, 85(4), 24m15365. https://doi.org/10.4088/JCP.24m15365
20. National Alliance on Mental Illness. (2024). Depression. https://www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Depression
21. National Center for Health Statistics. (2025). Depression prevalence in adolescents and adults: United States, August 2021–August 2023 (NCHS Data Brief No. 527). Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/products/databriefs/db527.htm
22. National Center for Health Statistics. (2024). Feelings of depression among adults: United States, 2021 (National Health Statistics Reports No. 199). Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/data/nhsr/nhsr199.pdf
23. National Institute of Mental Health. (2024). Depression. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/publications/depression
24. National Institute of Mental Health. (2021). Major depression. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/statistics/major-depression
25. Park, S., Kim, Y., & Lee, J. (2024). Global overview of suicidal behavior and risk factors among general population during the COVID-19 pandemic: A systematic review and meta-regression. Psychiatric Quarterly, 95(3), 411-432. https://doi.org/10.1007/s11126-024-10096-5
26. Pratt, L. A., & Brody, D. J. (2014). Depression in the U.S. household population, 2009–2012 (NCHS Data Brief No. 172). Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/data/databriefs/db172.pdf
27. Ribeiro, J. D., Huang, X., Fox, K. R., & Franklin, J. C. (2023). Depression and hopelessness as risk factors for suicide ideation, attempts and death: Meta-analysis of longitudinal studies. The British Journal of Psychiatry, 222(5), 190-198. https://doi.org/10.1192/bjp.2023.21
28. Saleem, M., Kühne, L., De Santis, K. K., Christianson, L., Brand, T., & Busse, H. (2024). Barriers and facilitators of implementing cognitive behavioral therapy: A systematic review based on the Consolidated Framework for Implementation. Implementation Science, 19(1), 45. https://doi.org/10.1186/s13012-024-01375-7
29. Singh, A., Kumar, P., & Sharma, S. (2024). Effectiveness of web-based cognitive behavioral therapy for depression: A systematic review of randomized controlled trials. Cureus, 16(7), e64372. https://doi.org/10.7759/cureus.64372
30. Substance Abuse and Mental Health Services Administration. (2024). 2024 National directory of mental health treatment facilities. U.S. Department of Health and Human Services. https://www.samhsa.gov/data/report/2024-national-directory-mental-health-treatment-facilities
31. Substance Abuse and Mental Health Services Administration. (2025). National guidelines for a behavioral health coordinated system. U.S. Department of Health and Human Services. https://988crisissystemshelp.samhsa.gov/sites/default/files/2025-04/national-guidelines-crisis-care-pep24-01-037.pdf
32. Substance Abuse and Mental Health Services Administration. (2023). SAMHSA seeks $10.8 billion in fiscal year 2024 to bolster mental health and substance use services across the nation. U.S. Department of Health and Human Services. https://www.samhsa.gov/newsroom/press-announcements/20230313/seeking-funding-fy-2024-bolster-mental-health-substance-use-services
33. Tai, A., Pincham, H., Basu, A., & Large, M. (2025). Meta-analysis of risk factors for suicide after psychiatric discharge and meta-regression of the duration of follow-up. Australian & New Zealand Journal of Psychiatry, 59(1), 52-67. https://doi.org/10.1177/00048674251348372
34. Turecki, G., Brent, D. A., Gunnell, D., O'Connor, R. C., Oquendo, M. A., Pirkis, J., & Stanley, B. H. (2024). Suicide and suicide risk. Nature Reviews Disease Primers, 10(1), 74. https://doi.org/10.1038/s41572-024-00586-5
35. World Health Organization. (2023). Depression and other common mental disorders: Global health estimates. https://www.who.int/publications/i/item/depression-global-health-estimates